ReviewCureus2025
Cryoneurolysis: A Comprehensive Review of Applications in Pain Management.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Ultrasound-Guided Percutaneous Cryoneurolysis for Refractory Lower-Limb Spasticity in Upper Motor Neuron Disorders: A Retrospective Case Series.Cardiovascular and interventional radiology · 2026Article
- Interventional Pain Procedures: A Narrative Review Focusing on Safety and Complications. Part 3 - Sympathetic and Ganglion-Targeted Techniques.Journal of pain research · 2026Review
- The synergistic protective effects of bioactive catechins in longjing tea: alleviate indomethacin-induced gastric toxicity through modulation of inflammatory and apoptotic pathways.Frontiers in pharmacology · 2026Article
- Cryoneurolysis: An Emerging Personalized Treatment Strategy for Significant Pelvic Pain.Journal of personalized medicine · 2025Review
- Comparative Outcomes and Safety of Radiofrequency Ablation and Cryoablation for Lumbar Facet Joint Degeneration: A Single-Center Retrospective Cohort Study with 24-Month Follow-Up.Journal of clinical medicine · 2025Article
- Targeting Phantom Pain with Psilocybin: Toward Integration with Adaptive Sensory Technologies.ACS medicinal chemistry letters · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pain management is an integral part of healthcare, and cryoneurolysis, a technique that uses extreme cold to disrupt nerve conduction, has demonstrated potential in managing both acute and chronic pain. It is an alternative for patients who do not respond to traditional pain management therapies. This review examines the efficacy, application, mechanism, limitations, challenges, and advancements in cryoneurolysis. Cryoneurolysis has broad applications, including acute pain management, reducing opioid dependency, and shortening hospital stays. It effectively treats chronic pain conditions like lumbar facet syndrome, phantom limb pain, occipital neuralgia, and, in some cases, unresponsiveness to traditional therapies. Furthermore, it offers values in tumor-induced neuropathies and postoperative pain. Cryoneurolysis has a favorable safety profile, presenting a low risk of minor complications such as infection and bruising, which resolve with proper care. Comparative studies indicate that cryoneurolysis, which induces Wallerian degeneration, is as effective as cooled radiofrequency ablation (CRFA), which achieves thermal nerve degradation to block pain transmission, particularly in knee osteoarthritis. However, its potential limitations impede widespread adoption, including small sample sizes, study heterogeneity, and the lack of standardized protocols. Future research should focus on large-scale trials, comparative studies with other pain management modalities, and developing standardized guidelines to enhance clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.